The twelve-month cost

Budgeting for a year matters more than it looks, because a meaningful share of people stop in the first eight weeks — and prepaying a year does not care.

Across the programmes where the monthly figure genuinely includes the medication, a year of compounded tirzepatide runs from about $1,500 at Trimi to $5,388 at Henry Meds. Same class of medication at both ends.

Budget for stopping, not just starting

Plan the year in two parts: the trial months where you find out whether you tolerate it, and the maintenance that follows if you do. Committing twelve months up front before you know which group you are in is the single most expensive mistake available here, and it is entirely avoidable.

What the table leaves out

• Labs. Where a clinician recommends bloodwork it is usually billed separately. Mochi is explicit about this; most are quiet.
• Dose escalation. On programmes that price by dose, your bill rises as the treatment starts working. Flat-rate programmes do not do this, which over a year is worth more than most advertised discounts.
• The months you do not take it. A meaningful share of people stop within eight weeks. A prepaid annual plan does not care.
• Supplies. Syringes, alcohol pads and a sharps container. Some programmes include them; most leave you to it.
• Shipping. Usually included, occasionally not. Worth confirming.

Annual plans: the real trade

The lowest rates in this market nearly all require a twelve-month commitment. The discount is genuine — often $600 or more a year — but you are lending a company a year of payments for a treatment you may not tolerate. A reasonable approach is to start month-to-month, get through two dose increases, then switch to annual once you know it suits you.

A worked example

1. Start month-to-month somewhere flat-rate. At Trimi that is $125 a month.
2. Budget an extra $50 to $200 once for labs, in case they are recommended.
3. Budget roughly $20 for a sharps container and spare syringes if your programme does not ship them.
4. After two dose increases, decide whether to switch to an annual plan and take the discount.
5. A realistic first year, going slowly and switching to annual at month three: roughly $1,500 to $1,980.

Full rankings in best tirzepatide providers and the cheapest programmes.

October 15 update: price the exit as well as the entry

The new MaxLife review shows why a starter-kit headline cannot supply a reliable twelve-month budget. Its advertised $89 semaglutide and $120 tirzepatide figures are qualified by a Starter Kit Plan. The reviewed public offer does not establish the full first charge and every renewal total. Multiplying either figure by twelve would create an unsupported annual quote.

Its thirty-day cancellation notice also belongs in the budget. Identify the next processing date and the notice deadline before assuming that stopping treatment will stop the next charge. Ask the clinician about any treatment change separately; cancellation is an administrative process, not a plan for stopping medication.

The LumiMeds review adds a second issue: installment payments and a fixed commitment are different things. Its product pages advertise no membership required, while its membership terms make the full selected term payable even when collected in installments. Establish whether that agreement applies to your purchase instead of assuming that a monthly payment creates a monthly exit.

LumiMeds also publishes a $100 cancellation fee, a pharmacy-submission cutoff and denial-refund language. The policies contain conflicts that the provider needs to resolve for the selected plan. A budget should record the total obligation, first and recurring charges, what happens after clinical denial, and the point at which an order becomes nonrefundable.

Use a written quote for a defined period and supply quantity. Add any separately quoted consultation, laboratory, supply or shipping expense, then record cancellation terms alongside the total. Neither a low entry price nor an advertised dose range determines which medicine or regimen is appropriate. The September examples above are retained for historical context and were not rechecked in this update.